Should You Buy Canopy Growth (TSX:WEED) Ahead of Earnings?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) releases its Q4 earnings later this month and investors are hoping a good result can help generate some excitement around the stock.

| More on:

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is going to be releasing its quarterly earnings later this month. And with its share price struggling since May, investors might be tempted to buy the stock before it announces its year-end results. Let’s take a closer look at the company to see whether it’s a good idea to buy now.

In its last earnings release back in February, Canopy Growth recorded significant sales growth numbers yet again. However, with a lot of cash burn and soaring expenses, there were plenty of red flags that kept the stock from gaining any momentum. The danger is that in Q4 it could be much of the same, as Canopy Growth has been very busy wheeling and dealing, which is sure to add some significant costs along the way, potentially sending the company  even deeper into the red.

While Canopy Growth is playing the long game and looking to strengthen its position over the years, in the short term, it’s going to lead to a lot of pain. However, investors are aware of these challenges and likely aren’t expecting the company to produce an (operating) profit anytime soon. Otherwise, Canopy Growth wouldn’t be at a market cap of around $20 billion today.

Is excitement surrounding Canadian pot stocks fading?

The big risk for Canopy Growth isn’t related to its financials or whether it will meet expectations; rather, it’s that investors have so many more options to choose from, as the U.S. cannabis industry has been growing and capturing a lot of attention lately. There’s no denying that the opportunity south of the border is a lot more lucrative given how strong sales have been in California and in other states.

While Canopy Growth certainly looks to capitalize that through its plans for hemp and the acquisition of Acreage Holdings, it’s still a long-term play that could take years to be realized. Meanwhile, companies in the U.S. are already expanding their reach throughout the country.

In order for investors to get excited about Canopy Growth, the company will have to announce some progress or expectations for its plans for the U.S. because strong results in Canada may not be enough to lift the stock from where it is today. Industry developments or company announcements have typically given Canopy Growth a big boost in the past. Investors have looked for signs of the growth that might be coming down the pipe rather than what has already been achieved thus far.

Bottom line

Barring a significant announcement made at the Q4 release, I would be surprised if the company sees a big boost in its share price even after a strong earnings result. However, given we’ve seen many misses in the industry since legalization, I wouldn’t hold out hope that Canopy Growth will produce a positive surprise this time around.

It may not be until edibles are legalized until we see some excitement returning to Canadian pot stocks. For now, however, the focus appears to have shifted away, and while that might make Canopy Growth an appealing buy today given its softer price, I wouldn’t expect the stock to get a big boost after the company releases its earnings this month.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »